Show simple item record

dc.contributor.authorFitton, Catherine A
dc.contributor.authorSteiner, Markus F C
dc.contributor.authorAucott, Lorna
dc.contributor.authorPell, J. P.
dc.contributor.authorMackay, Daniel F
dc.contributor.authorFleming, Michael
dc.contributor.authorMcLay, James S
dc.date.accessioned2017-07-25T10:00:19Z
dc.date.available2017-07-25T10:00:19Z
dc.date.issued2017-11
dc.identifier.citationFitton , C A , Steiner , M F C , Aucott , L , Pell , J P , Mackay , D F , Fleming , M & McLay , J S 2017 , ' In-utero exposure to antihypertensive medication and neonatal and child health outcomes : a systematic review ' , Journal of Hypertension , vol. 35 , no. 11 , pp. 2123-2137 . https://doi.org/10.1097/HJH.0000000000001456en
dc.identifier.issn0263-6352
dc.identifier.otherPURE: 104704202
dc.identifier.otherPURE UUID: 0ec88bfc-2236-407a-9d47-e4196449e32a
dc.identifier.otherPubMed: 28661961
dc.identifier.otherScopus: 85021692372
dc.identifier.urihttp://hdl.handle.net/2164/8990
dc.descriptionACKNOWLEDGEMENTS We acknowledge the support from the Farr Institute at Scotland. The Farr Institute at Scotland is supported by a 10-funder consortium: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates), the Wellcome Trust, (MRC Grant No: MR/K007017/1).en
dc.format.extent15
dc.language.isoeng
dc.relation.ispartofJournal of Hypertensionen
dc.rightsCopyright 2017 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/en
dc.subjectadverse drug eventen
dc.subjectantihypertensive agentsen
dc.subjectchild healthen
dc.subjectdrug exposure in pregnancyen
dc.subjectfemaleen
dc.subjecthypertensionen
dc.subjectin-utero exposureen
dc.subjectpharmacovigilanceen
dc.subjectpreeclampsiaen
dc.subjectpregnancy-induced hypertensionen
dc.subjectR Medicineen
dc.subjectArthritis Research UK (ARUK)en
dc.subjectBritish Heart Foundationen
dc.subjectCancer Research UKen
dc.subjectEconomic and Social Research Council (ESRC)en
dc.subjectEngineering and Physical Sciences Research Council (EPSRC)en
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/K007017/1en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subjectChief Scientist Office (CSO)en
dc.subjectWellcome Trusten
dc.subject.lccRen
dc.titleIn-utero exposure to antihypertensive medication and neonatal and child health outcomes : a systematic reviewen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Farr Aberdeenen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Public Health, Health Services and Primary Careen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1097/HJH.0000000000001456


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record